FDA Adverse Event Summary report: N

DEEP BRAIN STIMULATION DEVICES

MDR report key: 921663 · Received September 21, 2007

Report

Report Number
2182207-2007-03052
Date Received
September 21, 2007
Report Date
September 30, 2007
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
MHY
PMA / PMN Number
P960009
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

JOURNAL REFERENCE: GORGULHO A. ET AL. "INCIDENCE OF HEMORRHAGE ASSOCIATED WITH ELECTROPHYSIOLOGICAL STUDIES PERFORMED USING MACROELECTRODES AND MICROELECTRODES IN FUNCTIONAL NEUROSURGERY." J. NEUROSURG. 2005 MAY: 102(5): P888-896. THE ARTICLE ANALYZE THE INCIDENCE OF INTRACRANIAL IN PATIENTS WHO UNDERWENT PROCEDURES GUIDED BY MICROELECTRODE RECORDING (MER) RATHER THAN BY MICROELECTRODE STIMULATION ALONE. REPORTABLE EVENTS: 3389 LEAD (N=1) - FEMALE PT IMPLANTED FOR PARKINSONS EXPERIENCED MILD HEMIPARESIS FOLLOWING THE MICROELECTRODE RECORDING (MER) AND DBS LEAD PLACEMENT PROCEDURES. MRI IDENTIFIED AN INTRACRANIAL HEMORRHAGE SURROUNDING THE TRACT OF THE ELECTRODE AND FRONTAL REGION. THREE PASSES OF THE MICROELECTRODES RECORDING (MER) WAS REQUIRED PRIOR TO DBS LEAD PLACEMENT. NO SURGERY WAS REQUIRED DUE TO THE SIZE OF THE HEMORRHAGE. THE 3389 LEAD (N=1) - FEMALE PATIENT IMPLANTED FOR PARKINSONS EXPERIENCED SUBARACHNOID HEMORRHAGE AND EXPRESSIVE DYSPHASIA. TWO PASSES OF THE MICROELECTRODE RECORDING (MER) WAS REQUIRED PRIOR TO DBS LEAD PLACEMENT. CT/MRI IDENTIFIED AN INTRACRANIAL HEMORRHAGE SURROUNDING THE TRACK OF THE ELECTRODE. NO SEQUELA. THE 3387 LEAD (N=1) - FEMALE PATIENT IMPLANTED FOR POSTTRAUMATIC TREMOR EXPERIENCED ASYMPTOMATIC HEMORRHAGE. MRI IDENTIFIED AN INTRACRANIAL HEMORRHAGE SURROUNDING THE TRACK OF THE ELECTRODE. ONE PASS OF THE MACROELECTRODE RECORDING WAS REQUIRED PRIOR TO DBS LEAD PLACEMENT. NO SEQUELA.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 DEEP BRAIN STIMULATION DEVICES MHY MEDTRONIC NEUROMODULATION UNK

Patients

Seq Age Sex Outcome Treatment
1 YR